PADN-COLUMBUS Trial
Group II Pulmonary Hypertension
ClinicalPatient enrollment ongoing in Europe
Key Facts
Indication
Group II Pulmonary Hypertension
Phase
Clinical
Status
Patient enrollment ongoing in Europe
Company
About Pulnovo Medical
A Chinese medtech leader developing catheter-based denervation therapies for pulmonary hypertension and heart failure.
View full company profile